Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1263 (Beglan, Cryogenine, GR 33343 X, GR-33343X, GR-33343-X, Neovent, NSC-272693, Salmaterol, Salmeterol, Serevent, SN408D, Soltel, Vertine) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
β1-adrenoceptor/Beta-1 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL213] [GtoPdb: 28] [UniProtKB: P08588] | ||||||||
ChEMBL | Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay | B | 5.6 | pKi | 2511.89 | nM | Ki | Bioorg Med Chem Lett (2014) 24: 2625-2630 [PMID:24813741] |
ChEMBL | Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting | B | 5.64 | pKi | 2300 | nM | Ki | Bioorg Med Chem (2010) 18: 728-736 [PMID:20036561] |
ChEMBL | Displacement of [3H]CGP12177 from human beta-1 adrenoceptor | B | 6.1 | pKi | 801 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5302-5307 [PMID:20655218] |
ChEMBL | Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay | B | 6.11 | pKi | 784 | nM | Ki | Bioorg Med Chem Lett (2014) 24: 4341-4347 [PMID:25065493] |
ChEMBL | Binding affinity to adrenergic beta1 receptor | B | 6.3 | pIC50 | 501.19 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 4612-4616 [PMID:21723724] |
ChEMBL | Binding affinity to beta1 adrenoceptor | B | 6.3 | pIC50 | 501.19 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 689-695 [PMID:22079756] |
ChEMBL | Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay | B | 5.3 | pEC50 | 5011.87 | nM | EC50 | J Med Chem (2019) 62: 5111-5131 [PMID:31042379] |
ChEMBL | Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay | F | 5.91 | pEC50 | 1230.27 | nM | EC50 | Bioorg Med Chem (2019) 27: 2306-2314 [PMID:30392952] |
ChEMBL | Agonist activity at adrenergic beta1 receptor | F | 6.1 | pEC50 | 794.33 | nM | EC50 | Bioorg Med Chem Lett (2011) 21: 4612-4616 [PMID:21723724] |
ChEMBL | Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation | F | 6.1 | pEC50 | 794.33 | nM | EC50 | Bioorg Med Chem (2011) 19: 4192-4201 [PMID:21696967] |
ChEMBL | Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation | F | 6.1 | pEC50 | 794.33 | nM | EC50 | Bioorg Med Chem (2011) 19: 6026-6032 [PMID:21925889] |
ChEMBL | Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay | F | 6.1 | pEC50 | 794.33 | nM | EC50 | J Med Chem (2009) 52: 2280-2288 [PMID:19317397] |
ChEMBL | Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay | B | 6.1 | pEC50 | 794.33 | nM | EC50 | J Med Chem (2014) 57: 159-170 [PMID:24359185] |
ChEMBL | Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins | F | 6.1 | pEC50 | 794.33 | nM | EC50 | J Med Chem (2010) 53: 4522-4530 [PMID:20462258] |
ChEMBL | Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation | F | 6.43 | pEC50 | 371.54 | nM | EC50 | Eur J Med Chem (2021) 224: 113697-113697 [PMID:34273662] |
ChEMBL | Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay | F | 6.6 | pEC50 | 251.19 | nM | EC50 | Bioorg Med Chem Lett (2014) 24: 2871-2876 [PMID:24835980] |
ChEMBL | Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay | F | 6.6 | pEC50 | 251.19 | nM | EC50 | Bioorg Med Chem Lett (2014) 24: 2625-2630 [PMID:24813741] |
ChEMBL | Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay | F | 6.6 | pEC50 | 251.19 | nM | EC50 | Bioorg Med Chem Lett (2012) 22: 1213-1218 [PMID:22178551] |
ChEMBL | Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay | B | 6.7 | pEC50 | 199.53 | nM | EC50 | J Med Chem (2019) 62: 5111-5131 [PMID:31042379] |
ChEMBL | Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology | F | 7.17 | pEC50 | 67 | nM | EC50 | J Med Chem (2020) 63: 15218-15242 [PMID:33213146] |
β1-adrenoceptor/Beta-1 adrenergic receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3440] [GtoPdb: 28] [UniProtKB: P34971] | ||||||||
ChEMBL | Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay | B | 6.26 | pKi | 550 | nM | Ki | J Med Chem (2019) 62: 5111-5131 [PMID:31042379] |
Beta-1 adrenergic receptor in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5471] [UniProtKB: B0FL73] | ||||||||
ChEMBL | Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction | F | 8.3 | pEC50 | 5.01 | nM | EC50 | J Med Chem (2009) 52: 2280-2288 [PMID:19317397] |
β2-adrenoceptor/Beta-2 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550] | ||||||||
ChEMBL | Displacement of [3H]DHA from inactive/G protein-uncoupled human beta2-AR expressed in CHO cell membranes assessed as intrinsic Kd by liquid scintillation counting | B | 5.96 | pKd | 1100 | nM | Kd | J Med Chem (2016) 59: 5780-5789 [PMID:27239696] |
ChEMBL | Displacement of [3H]DHA from inactive/G protein-uncoupled human beta2-AR expressed in CHO cell membranes by liquid scintillation counting | B | 9.52 | pKd | 0.3 | nM | Kd | J Med Chem (2016) 59: 5780-5789 [PMID:27239696] |
ChEMBL | Displacement of [125I]-CYP from human beta2-adrenergic receptor Y308A mutant expressed in COS-7 cells by gamma counting | B | 6.74 | pKi | 184 | nM | Ki | Bioorg Med Chem (2010) 18: 728-736 [PMID:20036561] |
ChEMBL | Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta2 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay | B | 8.49 | pKi | 3.2 | nM | Ki | Bioorg Med Chem Lett (2014) 24: 4341-4347 [PMID:25065493] |
ChEMBL | Displacement of [3H]CGP12177 from human beta2 adrenoceptor | B | 8.49 | pKi | 3.2 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5302-5307 [PMID:20655218] |
ChEMBL | Displacement of [3H]dihydroalprenolol from human beta2 adrenergic receptor expressing cell membrane by competition binding assay | B | 8.6 | pKi | 2.51 | nM | Ki | Bioorg Med Chem Lett (2014) 24: 2871-2876 [PMID:24835980] |
ChEMBL | Displacement of [3H]dihydroalprenolol from beta2 receptor (unknown origin) by liquid scintillation counting and cell based assay | B | 8.6 | pKi | 2.51 | nM | Ki | Bioorg Med Chem Lett (2014) 24: 2625-2630 [PMID:24813741] |
ChEMBL | Displacement of [3H]-dihydroalprenolol from human beta2-adrenoceptor expressed in HEK cells after 4 hrs | B | 8.62 | pKi | 2.4 | nM | Ki | Bioorg Med Chem Lett (2011) 21: 1354-1358 [PMID:21310610] |
ChEMBL | Displacement of [125I]-CYP from human beta2-adrenergic receptor expressed in COS-7 cells by gamma counting | B | 8.82 | pKi | 1.5 | nM | Ki | Bioorg Med Chem (2010) 18: 728-736 [PMID:20036561] |
ChEMBL | Binding affinity for human beta-2 adrenergic receptor | B | 9 | pKi | 1 | nM | Ki | Bioorg Med Chem Lett (2004) 14: 4705-4710 [PMID:15324892] |
ChEMBL | Displacement of [125I]cyanopindolol from human recombinant beta2 adrenergic receptor expressed in CHO cells by filtration assay | B | 9.41 | pKi | 0.39 | nM | Ki | J Med Chem (2010) 53: 3675-3684 [PMID:20402514] |
ChEMBL | Displacement of [3H]-CGP-12177 from human beta2-adrenergic receptor expressed in CHO cells after 60 mins by radioligand competition binding assay | B | 9.6 | pKi | 0.25 | nM | Ki | J Med Chem (2019) 62: 5111-5131 [PMID:31042379] |
ChEMBL | Displacement of [3H]CGP12177 from human beta2 receptor expressed in CHO cells | B | 9.74 | pKi | 0.18 | nM | Ki | Bioorg Med Chem (2016) 24: 2641-2653 [PMID:27132867] |
ChEMBL | Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting | B | 8.3 | pIC50 | 5.01 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 1213-1218 [PMID:22178551] |
ChEMBL | Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometry | F | 9.1 | pEC50 | 0.79 | nM | EC50 | Bioorg Med Chem Lett (2012) 22: 689-695 [PMID:22079756] |
ChEMBL | Agonist activity at beta2-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay | B | 9.1 | pEC50 | 0.79 | nM | EC50 | J Med Chem (2019) 62: 5111-5131 [PMID:31042379] |
ChEMBL | Agonist activity at human adrenergic beta2 receptor expressed in H292 cells assessed as intracellular cAMP accumulation after 1 hr | F | 9.1 | pEC50 | 0.79 | nM | EC50 | Bioorg Med Chem Lett (2011) 21: 4027-4031 [PMID:21652207] |
ChEMBL | Agonist activity at human adrenergic beta2 receptor expressed in H292 cells assessed as stimulation of cAMP accumulation after 60 mins | F | 9.1 | pEC50 | 0.79 | nM | EC50 | Bioorg Med Chem Lett (2011) 21: 4612-4616 [PMID:21723724] |
ChEMBL | Agonist activity at human beta2 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology | F | 9.15 | pEC50 | 0.71 | nM | EC50 | J Med Chem (2020) 63: 15218-15242 [PMID:33213146] |
ChEMBL | Agonist activity at human beta2 receptor in BEAS-2B cells assessed as cAMP accumulation by radioimmunoassay | F | 9.3 | pEC50 | 0.5 | nM | EC50 | Bioorg Med Chem Lett (2014) 24: 2625-2630 [PMID:24813741] |
ChEMBL | Agonist activity at beta2-adrenoceptor endogenously expressed in human BEAS-2B cells assessed as cAMP accumulation by homogeneous radioimmunoassay | F | 9.3 | pEC50 | 0.5 | nM | EC50 | Bioorg Med Chem Lett (2012) 22: 1213-1218 [PMID:22178551] |
ChEMBL | Agonist activity at human beta2 adrenergic receptor in human BEAS-2B cells by cAMP accumulation assay | F | 9.3 | pEC50 | 0.5 | nM | EC50 | Bioorg Med Chem Lett (2014) 24: 2871-2876 [PMID:24835980] |
ChEMBL | Agonist activity at human beta2-adrenoceptor expressed in HEK cells assessed as increase of cAMP level after 10 mins by radioimmunoassay | F | 9.48 | pEC50 | 0.33 | nM | EC50 | Bioorg Med Chem Lett (2011) 21: 1354-1358 [PMID:21310610] |
ChEMBL | Agonist activity at human beta2 adrenergic receptor assessed as increase in cAMP level by whole cell assay | F | 9.49 | pEC50 | 0.32 | nM | EC50 | J Med Chem (2010) 53: 3675-3684 [PMID:20402514] |
ChEMBL | Agonist activity at human beta2 adrenergic receptor expressed in cells by cAMP accumulation assay | F | 9.5 | pEC50 | 0.32 | nM | EC50 | Bioorg Med Chem Lett (2014) 24: 2871-2876 [PMID:24835980] |
ChEMBL | Agonist activity at recombinant human beta2-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay | F | 9.5 | pEC50 | 0.32 | nM | EC50 | Bioorg Med Chem Lett (2012) 22: 1213-1218 [PMID:22178551] |
ChEMBL | Agonist activity at human recombinant beta2 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay | F | 9.5 | pEC50 | 0.32 | nM | EC50 | Bioorg Med Chem Lett (2014) 24: 2625-2630 [PMID:24813741] |
ChEMBL | Agonist activity at human adrenergic beta2 receptor expressed in CHO cells assessed as cAMP accumulation | F | 9.6 | pEC50 | 0.25 | nM | EC50 | Bioorg Med Chem (2011) 19: 4192-4201 [PMID:21696967] |
ChEMBL | Agonist activity at human beta2 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay | F | 9.6 | pEC50 | 0.25 | nM | EC50 | J Med Chem (2014) 57: 159-170 [PMID:24359185] |
ChEMBL | Agonist activity at human cloned beta2 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay | F | 9.6 | pEC50 | 0.25 | nM | EC50 | J Med Chem (2009) 52: 2280-2288 [PMID:19317397] |
ChEMBL | Agonist activity at human recombinant beta2 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins | F | 9.6 | pEC50 | 0.25 | nM | EC50 | J Med Chem (2010) 53: 4522-4530 [PMID:20462258] |
ChEMBL | Agonist activity at human beta2 receptor expressed in CHO cells assessed as cAMP accumulation | F | 9.6 | pEC50 | 0.25 | nM | EC50 | Bioorg Med Chem (2011) 19: 6026-6032 [PMID:21925889] |
ChEMBL | Agonist activity at human beta2 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation | F | 9.87 | pEC50 | 0.13 | nM | EC50 | Eur J Med Chem (2021) 224: 113697-113697 [PMID:34273662] |
ChEMBL | Agonist activity at beta2-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GSK2 and coelenterazine 400a by BRET assay | B | 9.9 | pEC50 | 0.13 | nM | EC50 | J Med Chem (2019) 62: 5111-5131 [PMID:31042379] |
GtoPdb | - | - | 9.92 | pEC50 | 0.12 | nM | EC50 | Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599] |
ChEMBL | Agonist activity at beta2-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GSK5 and coelenterazine 400a by BRET assay | B | 10.1 | pEC50 | 0.08 | nM | EC50 | J Med Chem (2019) 62: 5111-5131 [PMID:31042379] |
ChEMBL | Agonist activity at human beta2 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay | F | 10.11 | pEC50 | 0.08 | nM | EC50 | Bioorg Med Chem (2019) 27: 2306-2314 [PMID:30392952] |
ChEMBL | Agonist activity at human recombinant beta2 adrenergic receptor expressed in CHO cells assessed as elevation in cAMP level after 1 hr by flashplate method | F | 10.15 | pEC50 | 0.07 | nM | EC50 | J Med Chem (2010) 53: 6640-6652 [PMID:20804199] |
ChEMBL | Agonist activity at human recombinant beta-2 adrenoceptor expressed in CHO cells assessed as elevation of cAMP | F | 10.15 | pEC50 | 0.07 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 4012-4015 [PMID:17498952] |
ChEMBL | Agonist activity at human recombinant adrenergic beta-2 receptor expressed in CHO cells assessed as elevation in cAMP levels | F | 10.15 | pEC50 | 0.07 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 6188-6191 [PMID:17897826] |
ChEMBL | Agonist activity at human beta2 adrenoreceptor overexpressed in human HEK293 cells assessed as cAMP accumulation incubated for 60 mins by HTRF assay | F | 10.35 | pEC50 | 0.04 | nM | EC50 | Bioorg Med Chem (2020) 28: 115178-115178 [PMID:31753798] |
Beta-2 adrenergic receptor in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5414] [UniProtKB: Q8K4Z4] | ||||||||
ChEMBL | Agonist activity at beta2 adrenergic receptor in guinea pig tracheal strip assessed as inhibition of electrically-induced bronchocontractile response after 30 mins | F | 8.46 | pIC50 | 3.5 | nM | IC50 | J Med Chem (2010) 53: 3675-3684 [PMID:20402514] |
ChEMBL | Agonist activity at adrenergic beta2 receptor in electrically-stimulated Dunkin-Hartley guinea pig tracheal strip assessed as inhibition of contraction | B | 8.46 | pIC50 | 3.5 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 4341-4347 [PMID:25065493] |
ChEMBL | Agonist activity at beta2 receptor in guinea pig trachea assessed as slow onset of inhibition of electrically stimulated contraction | B | 7.5 | pEC50 | 31.62 | nM | EC50 | Bioorg Med Chem Lett (2014) 24: 2625-2630 [PMID:24813741] |
ChEMBL | Agonist activity at adrenergic beta2 receptor in guinea pig trachea assessed as inhibition of electrically-stimulated contraction | F | 8.3 | pEC50 | 5.01 | nM | EC50 | Bioorg Med Chem (2011) 19: 4192-4201 [PMID:21696967] |
ChEMBL | Agonist activity at beta2 adrenergic receptor in guinea pig tracheal strip assessed as inhibition of electrically-induced bronchocontractile response | F | 8.3 | pEC50 | 5.01 | nM | EC50 | Bioorg Med Chem (2011) 19: 6026-6032 [PMID:21925889] |
ChEMBL | Agonist activity at beta2 adrenoceptor in guinea pig trachea assessed as inhibition of histamine-induced contraction | B | 8.57 | pEC50 | 2.7 | nM | EC50 | Bioorg Med Chem Lett (2015) 25: 5121-5126 [PMID:26471092] |
β3-adrenoceptor/Beta-3 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL246] [GtoPdb: 30] [UniProtKB: P13945] | ||||||||
ChEMBL | Agonist activity at human cloned beta3 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay | F | 5.9 | pEC50 | 1258.93 | nM | EC50 | J Med Chem (2009) 52: 2280-2288 [PMID:19317397] |
ChEMBL | Agonist activity at human recombinant beta3 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins | F | 5.9 | pEC50 | 1258.93 | nM | EC50 | J Med Chem (2010) 53: 4522-4530 [PMID:20462258] |
ChEMBL | Agonist activity at human adrenergic beta3 receptor expressed in CHO cells assessed as cAMP accumulation | F | 5.9 | pEC50 | 1258.93 | nM | EC50 | Bioorg Med Chem (2011) 19: 4192-4201 [PMID:21696967] |
ChEMBL | Agonist activity at human beta3 receptor expressed in CHO cells assessed as cAMP accumulation | F | 5.9 | pEC50 | 1258.93 | nM | EC50 | Bioorg Med Chem (2011) 19: 6026-6032 [PMID:21925889] |
ChEMBL | Agonist activity at human beta3 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay | B | 5.9 | pEC50 | 1258.93 | nM | EC50 | J Med Chem (2014) 57: 159-170 [PMID:24359185] |
ChEMBL | Agonist activity at human recombinant beta3 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay | F | 6 | pEC50 | 1000 | nM | EC50 | Bioorg Med Chem Lett (2014) 24: 2625-2630 [PMID:24813741] |
ChEMBL | Agonist activity at human beta3 adrenergic receptor expressed in cells by cAMP accumulation assay | F | 6 | pEC50 | 1000 | nM | EC50 | Bioorg Med Chem Lett (2014) 24: 2871-2876 [PMID:24835980] |
D2 receptor/Dopamine D2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL217] [GtoPdb: 215] [UniProtKB: P14416] | ||||||||
ChEMBL | Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells | B | 4.49 | pKi | 32000 | nM | Ki | Bioorg Med Chem (2016) 24: 2641-2653 [PMID:27132867] |
D3 receptor/Dopamine D3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL234] [GtoPdb: 216] [UniProtKB: P35462] | ||||||||
ChEMBL | Displacement of [125I]7-HO-PIPAT from human D3R expressed in HEK cells | B | 5.98 | pKi | 1049 | nM | Ki | Bioorg Med Chem Lett (2014) 24: 4341-4347 [PMID:25065493] |
ChEMBL data shown on this page come from version 32:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]